Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OXFD

Oxford Immunotec Global (OXFD) Stock Price, News & Analysis

Oxford Immunotec Global logo

About Oxford Immunotec Global Stock (NASDAQ:OXFD)

Advanced Chart

Key Stats

Today's Range
$21.99
$21.99
50-Day Range
$21.88
$21.99
52-Week Range
$8.37
$23.11
Volume
N/A
Average Volume
1.10 million shs
Market Capitalization
$570.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OXFD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Immunotec Global and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OXFD Stock News Headlines

A Game-Changing Vaccine
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel
Nigeria rolls out new Oxford R21 malaria vaccine
See More Headlines

OXFD Stock Analysis - Frequently Asked Questions

Oxford Immunotec Global PLC (NASDAQ:OXFD) issued its earnings results on Tuesday, November, 3rd. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). The company had revenue of $19.44 million for the quarter, compared to analyst estimates of $18.58 million. Oxford Immunotec Global had a negative trailing twelve-month return on equity of 8.39% and a negative net margin of 30.51%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Immunotec Global investors own include Intel (INTC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Dynavax Technologies (DVAX), Enterprise Products Partners (EPD) and Gold Resource (GORO).

Company Calendar

Last Earnings
11/03/2020
Today
8/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:OXFD
CIK
1586049
Fax
N/A
Employees
273
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.81 million
Net Margins
-30.51%
Pretax Margin
N/A
Return on Equity
-8.39%
Return on Assets
-7.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.96
Quick Ratio
14.85

Sales & Book Value

Annual Sales
$73.71 million
Price / Sales
7.75
Cash Flow
$0.02 per share
Price / Cash Flow
1,408.78
Book Value
$8.08 per share
Price / Book
2.72

Miscellaneous

Outstanding Shares
25,962,000
Free Float
N/A
Market Cap
$570.90 million
Optionable
Not Optionable
Beta
1.42
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:OXFD) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners